Q2 2024 · 13F-HR
Flagship Pioneering, LLCholdings as filed
Filed 2024-08-14 · accession 0000950123-24-008727
$843.4M
Reported value
6
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 60770K107 | MRNA | Moderna Inc | $550.1M | 65.2% | 4,632,149 | Common | SHARED |
| 799566104 | SANA | Sana Biotechnology Inc | $136.5M | 16.2% | 25,001,856 | Common | SHARED |
| 344174107 | FHTX | Foghorn Therapeutics Inc | $72.9M | 8.64% | 12,674,120 | Common | SHARED |
| 68217N105 | — | Omega Therapeutics Inc | $60.5M | 7.17% | 29,225,579 | Common | SHARED |
| 81750R102 | MCRB1EUR | Seres Therapeutics Inc | $16.7M | 1.98% | 23,117,045 | Common | SHARED |
| 87184Q206 | SYRS | Syros Pharmaceuticals Inc | $6.7M | 0.79% | 1,293,849 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.